Tacalcitol

	WikiDoc Resources for Tacalcitol
Articles
Most recent articles on Tacalcitol Most cited articles on Tacalcitol Review articles on Tacalcitol Articles on Tacalcitol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tacalcitol Images of Tacalcitol Photos of Tacalcitol Podcasts & MP3s on Tacalcitol Videos on Tacalcitol
Evidence Based Medicine
Cochrane Collaboration on Tacalcitol Bandolier on Tacalcitol TRIP on Tacalcitol
Clinical Trials
Ongoing Trials on Tacalcitol at Clinical Trials.gov Trial results on Tacalcitol Clinical Trials on Tacalcitol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tacalcitol NICE Guidance on Tacalcitol NHS PRODIGY Guidance FDA on Tacalcitol CDC on Tacalcitol
Books
Books on Tacalcitol
News
Tacalcitol in the news Be alerted to news on Tacalcitol News trends on Tacalcitol
Commentary
Blogs on Tacalcitol
Definitions
Definitions of Tacalcitol
Patient Resources / Community
Patient resources on Tacalcitol Discussion groups on Tacalcitol Patient Handouts on Tacalcitol Directions to Hospitals Treating Tacalcitol Risk calculators and risk factors for Tacalcitol
Healthcare Provider Resources
Symptoms of Tacalcitol Causes & Risk Factors for Tacalcitol Diagnostic studies for Tacalcitol Treatment of Tacalcitol
Continuing Medical Education (CME)
CME Programs on Tacalcitol
International
Tacalcitol en Espanol Tacalcitol en Francais
Business
Tacalcitol in the Marketplace Patents on Tacalcitol
Experimental / Informatics
List of terms related to Tacalcitol

Tacalcitol
Clinical data
Synonyms	(1α,24R)-1,24-Dihydroxyvitamin D3
AHFS/Drugs.com	International Drug Names
Routes of; administration	Topical
ATC code	D05AX04 (WHO) ;
Identifiers
	IUPAC name (1S,3R,5Z,7E,24R)-9,10-secocholesta-5,7,10-triene-1,3,24-triol;
CAS Number	57333-96-7 ;
PubChem CID	5283734;
IUPHAR/BPS	2780;
ChemSpider	4446823 ;
UNII	C2W72OJ5ZU;
ChEMBL	ChEMBL340361 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C27H44O3
Molar mass	416.64
3D model (JSmol)	Interactive image;
	SMILES O[C@@H]1CC(\C(=C)[C@@H](O)C1)=C\C=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)CC[C@@H](O)C(C)C)C;
	InChI InChI=1S/C27H44O3/c1-17(2)25(29)13-8-18(3)23-11-12-24-20(7-6-14-27(23,24)5)9-10-21-15-22(28)16-26(30)19(21)4/h9-10,17-18,22-26,28-30H,4,6-8,11-16H2,1-3,5H3/b20-9+,21-10-/t18-,22-,23-,24+,25-,26+,27-/m1/s1 ; Key:BJYLYJCXYAMOFT-RSFVBTMBSA-N ;
(what is this?) (verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tacalcitol (1,24-dihydroxyvitamin D₃) is a synthetic vitamin D₃ analog.^[1]

Tacalcitol is marketed under several names, including Curatoderm and Bonalfa.

Mechanism

Tacalcitol reduces excessive cell turnover in the epidermis by interacting with vitamin D receptors on keratinocytes.

Uses

It is usually prescribed by a general practitioner or dermatologist for the treatment of psoriasis, chronic chapped lips and other severe dry skin conditions because of its ability to reduce excessive skin cell turnover. It is available as an ointment or lotion.

It has also been used for vitiligo^[2] and Hailey-Hailey disease.^[3]

References

↑ Fukuoka M, Sakurai K, Ohta T, Kiyoki M, Katayama I (2001). "Tacalcitol, an active vitamin D3, induces nerve growth factor production in human epidermal keratinocytes". Skin Pharmacol. Appl. Skin Physiol. 14 (4): 226–33. doi:10.1159/000056351. PMID 11464105.
↑ Leone G, Pacifico A, Iacovelli P, Paro Vidolin A, Picardo M (March 2006). "Tacalcitol and narrow-band phototherapy in patients with vitiligo". Clin. Exp. Dermatol. 31 (2): 200–5. doi:10.1111/j.1365-2230.2005.02037.x. PMID 16487090.
↑ Aoki T, Hashimoto H, Koseki S, Hozumi Y, Kondo S (November 1998). "1alpha,24-dihydroxyvitamin D3 (tacalcitol) is effective against Hailey-Hailey disease both in vivo and in vitro". Br. J. Dermatol. 139 (5): 897–901. doi:10.1046/j.1365-2133.1998.02522.x. PMID 9892963.

Template:Antipsoriatics

[pmid11464105-1] Fukuoka M, Sakurai K, Ohta T, Kiyoki M, Katayama I (2001). "Tacalcitol, an active vitamin D3, induces nerve growth factor production in human epidermal keratinocytes". Skin Pharmacol. Appl. Skin Physiol. 14 (4): 226–33. doi:10.1159/000056351. PMID 11464105.

[pmid16487090-2] Leone G, Pacifico A, Iacovelli P, Paro Vidolin A, Picardo M (March 2006). "Tacalcitol and narrow-band phototherapy in patients with vitiligo". Clin. Exp. Dermatol. 31 (2): 200–5. doi:10.1111/j.1365-2230.2005.02037.x. PMID 16487090.

[pmid9892963-3] Aoki T, Hashimoto H, Koseki S, Hozumi Y, Kondo S (November 1998). "1alpha,24-dihydroxyvitamin D3 (tacalcitol) is effective against Hailey-Hailey disease both in vivo and in vitro". Br. J. Dermatol. 139 (5): 897–901. doi:10.1046/j.1365-2133.1998.02522.x. PMID 9892963.

[1]

[2]

[3]

Clinical data

Synonyms	(1α,24R)-1,24-Dihydroxyvitamin D₃
AHFS/Drugs.com	International Drug Names
Routes of administration	Topical
ATC code	D05AX04 (WHO)
Identifiers
IUPAC name (1S,3R,5Z,7E,24R)-9,10-secocholesta-5,7,10-triene-1,3,24-triol
CAS Number	57333-96-7^Y
PubChem CID	5283734
IUPHAR/BPS	2780
ChemSpider	4446823^N
UNII	C2W72OJ5ZU
ChEMBL	ChEMBL340361^N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₇H₄₄O₃
Molar mass	416.64
3D model (JSmol)	Interactive image
SMILES O[C@@H]1CC(\C(=C)[C@@H](O)C1)=C\C=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)CC[C@@H](O)C(C)C)C
InChI InChI=1S/C27H44O3/c1-17(2)25(29)13-8-18(3)23-11-12-24-20(7-6-14-27(23,24)5)9-10-21-15-22(28)16-26(30)19(21)4/h9-10,17-18,22-26,28-30H,4,6-8,11-16H2,1-3,5H3/b20-9+,21-10-/t18-,22-,23-,24+,25-,26+,27-/m1/s1^N Key:BJYLYJCXYAMOFT-RSFVBTMBSA-N^N
^NY (what is this?) (verify)

Tacalcitol

Overview

Mechanism

Uses

References

Navigation menu